Similarly, abnormal upregulation of selenium uptake and selenocysteine biosynthesis occurs in many cancer cells, including breast cancers (Carlisle et al., 2020) and acute myeloid leukemia (Eagle et al., 2022), making SEPHS2 crucial for their survival but not for normal cells. This evidence concerns the gene SEPHS2 and breast carcinoma.